Sarepta Therapeutics, Inc. (SRPT)
15.90
+0.35
(+2.25%)
USD |
NASDAQ |
Jun 09, 16:00
15.76
-0.14
(-0.88%)
After-Hours: 19:34
Sarepta Therapeutics Shareholders Equity (Quarterly) : 1.505B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
| Moderna, Inc. | 7.408B |
| Denali Therapeutics, Inc. | 926.10M |
| Twist Bioscience Corp. | 455.09M |
| Revolution Medicines, Inc. | 1.500B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.179B |
| Total Liabilities (Quarterly) | 1.674B |
| Debt to Equity Ratio | 0.6888 |
| Current Ratio | 4.628 |
| Net Debt Paydown Yield | 2.67% |